Form 4: Teradyne CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Teradyne's President and CEO, Gregory Stephen Smith, sold 1,108 shares of common stock for $201.31 per share as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Gregory Stephen Smith, President and CEO, and a Director of Teradyne, Inc. (TER), sold 1,108 shares of common stock.
- The transaction occurred on December 12, 2025, at a price of $201.31 per share.
- The sale was executed pursuant to a Rule 10b5-1 sales plan adopted by Mr. Smith on February 4, 2025.
- Following this transaction, Mr. Smith directly beneficially owns 93,408.995 shares of Teradyne common stock.
Sentiment
Score: 5
Explanation: Neutral. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which mitigates any negative sentiment typically associated with insider selling. It does not provide new positive or negative operational information.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a planned transaction rather than an immediate reaction to new information.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived as a slight negative signal regarding management's outlook on the stock's short-term appreciation potential.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This filing is a routine insider transaction and does not provide specific industry context. Teradyne operates in the semiconductor test equipment and industrial automation markets. Insider sales, especially under 10b5-1 plans, are common across all industries for personal financial planning.
Comparison to Industry Standards
- This is a standard insider transaction disclosure. There are no specific results to compare to global benchmarks or comparable companies/projects. The execution of a 10b5-1 plan is a common practice for executives to manage their equity holdings in a compliant manner.
Related Party Transactions
- The transaction involves an insider (CEO) selling company stock, which is a standard disclosure for beneficial ownership changes. No other related party dealings are detailed.
Stakeholder Impact
- Shareholders: May interpret the sale as a minor negative signal, though the 10b5-1 plan mitigates this. The impact on the overall share price from this specific transaction is likely minimal given the small number of shares relative to total outstanding shares.
- Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date the Rule 10b5-1 sales plan was adopted by Gregory Stephen Smith. |
| 12/12/2025 | Date of the reported transaction (sale of common stock). |
| 12/15/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine insider sale under a pre-arranged 10b5-1 plan. Such transactions are typically for personal financial planning and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this information. Investors should continue to evaluate Teradyne based on its operational performance, financial results, and market position.
Keywords
Teradyne, TER, Form 4, Insider Trading, Stock Sale, Gregory Stephen Smith, CEO, 10b5-1 Plan, Beneficial Ownership, Semiconductor Equipment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.